BioSpace News Archive

Increasing prevalence of various genetic disorders, chronic diseases and viral infections, rising research based activities in pharmaceutical and biotechnology companies, and increasing applications of synthesized oligonucleotides are some key factors expected to drive global market growth.

Increasing prevalence of degenerative disc disease, rising geriatric population, and increasing cases of road accidents and fatal falls worldwide are some key factors expected to drive global market growth.

Artificial Joints Market is estimated to register a CAGR of 6%, generating USD 32.70 Billion in terms of revenue by 2028 from USD 20.47 Billion in 2020.

The report consists of quantitative and qualitative research on the market performed by our market experts.

Our market experts have determined the current financial positions of the leading industry players in the report leveraging advanced analytical tools such as Porter’s Five Forces Analysis, SWOT analysis, and investment assessment.

Forecast to 2028,’ thoroughly examines the Microscopy Devices industry to provide essential data & information for the targeted readers.

Forecast to 2028,’ thoroughly examines the Injectable Sumatriptan industry to provide essential data & information for the targeted readers.

Sparrow Pharmaceuticals, an emerging, clinical-stage biopharmaceutical company developing novel, targeted therapies to address unmet needs in both endocrinology and rheumatology, today announced that it will present new pharmacology data at the 2022 Annual European Congress of Rheumatology (EULAR) on its lead candidate, SPI-62, an HSD-1 inhibitor.

Forecast to 2028,’ thoroughly examines the Retinal Implants industry to provide essential data & information for the targeted readers.

A multicenter, prospective, randomized controlled trial is designed to assess the effectiveness of three different disc replacement devices used for two-level symptomatic cervical disc disease.